Legal Representation
Attorney
Nazly Aileen Bayramoglu
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 29, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Sep 1, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 1, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 1, 2020 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Sep 1, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 1, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 1, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 29, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 13, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 24, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 9, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 27, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 7, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 6, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 23, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, for treating diseases of cardiovascular and cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating diseases of immune system and musculo-skeletal system; Chemico-pharmaceutical preparations, namely, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, for treating diseases of respiratory system, digestive system, endocrine system, and for treating hypersensitivity diseases; Capsules for pharmaceutical purposes, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of immune system and musculo-skeletal system; Medicines for human purpose, for treating diseases of cardiovascular and cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating diseases of immune system and musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the musculo-skeletal system; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of immune system and musculo-skeletal system
Additional Information
Design Mark
The mark consists of a black circle which is slightly open at the top; protruding downward from the right side of said opening is a black scythe-like design the circular blade of which merges with the bottom portion of the circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005